ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease - European Society of Gynaecological Oncology (ESGO) / European Society for Medical Oncology (ESMO) / European Society of Pathology (ESP)

46 participants from 15 countries across Europe, Asia and the USA contributed to the ESGO–ESMO–ESP consensus conference.

Recommendations cover diagnosis and management of early, advanced and recurrent ovarian cancers.

Recommendations are based on available data and/or the experts’ collective, multidisciplinary opinions and experience.

The results, including questions, recommendations and supporting evidence for each recommendation, are detailed here.


Read full Guideline